Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Effect of FDC I/H Treatment on Mortality and Morbidity by Median Baseline SBP
Effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine (FDC I/H) treatment on mortality and morbidity in patients above or below the median baseline systolic blood pressure (SBP) shown as point estimates of the hazard ratios (HR) with 95% confidence intervals (CI). HF = heart failure.
|
